{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:52:58Z","timestamp":1792119178774,"version":"4.4.0"},"reference-count":215,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.neuint.2024.105761","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T11:30:36Z","timestamp":1715081436000},"page":"105761","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Advances in Alzheimer's disease: A multifaceted review of potential therapies and diagnostic techniques for early detection"],"prefix":"10.1016","volume":"177","author":[{"given":"Monika","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukesh Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2024.105761_bib1","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s10534-023-00525-6","article-title":"Myco-fabricated ZnO nanoparticles ameliorate neurotoxicity in mice model of Alzheimer's disease via acetylcholinesterase inhibition and oxidative stress reduction","volume":"36","author":"Abd Elmonem","year":"2023","journal-title":"Biometals"},{"key":"10.1016\/j.neuint.2024.105761_bib2","article-title":"Perturbed mitochondria-ER contacts in live neurons that model the amyloid pathology of Alzheimer's disease","volume":"132","author":"Adami","year":"2019","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.neuint.2024.105761_bib3","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.bbrc.2016.08.043","article-title":"Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders","volume":"483","author":"Agarwal","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuint.2024.105761_bib4","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.bmcl.2005.10.042","article-title":"Isolation and cholinesterase-inhibition studies of sterols from Haloxylon recurvum","volume":"16","author":"Ahmed","year":"2006","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.neuint.2024.105761_bib5","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s10571-022-01230-7","article-title":"Tau aggregation inhibiting peptides as potential therapeutics for alzheimer disease","volume":"43","author":"Aillaud","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuint.2024.105761_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271138","article-title":"Effects of antidiabetic agents on Alzheimer's disease biomarkers in experimentally induced hyperglycemic rat model by streptozocin","volume":"17","author":"Ali","year":"2022","journal-title":"PLoS One"},{"issue":"2021","key":"10.1016\/j.neuint.2024.105761_bib7","article-title":"Repetitive transcranial magnetic stimulation in the treatment of alzheimer's disease and other dementias","volume":"9","author":"Aloizou","year":"2021","journal-title":"Healthcare"},{"key":"10.1016\/j.neuint.2024.105761_bib8","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1517\/13543784.2015.1075002","article-title":"Early investigational drugs targeting tau protein for the treatment of Alzheimer's disease","volume":"24","author":"Anand","year":"2015","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.neuint.2024.105761_bib9","doi-asserted-by":"crossref","DOI":"10.2174\/1567205014666170706112701","article-title":"Developmental expression and dysregulation of miR-146a and miR-155 in down's syndrome and mouse models of down's syndrome and alzheimer's disease","volume":"14","author":"Arena","year":"2017","journal-title":"Curr. Alzheimer Res."},{"issue":"2 45","key":"10.1016\/j.neuint.2024.105761_bib10","first-page":"417","article-title":"The effects of different acetylcholinesterase inhibitors on EEG patterns in patients with Alzheimer's disease: a systematic review","volume":"45","author":"Arjmandi-Rad","year":"2023","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.neuint.2024.105761_bib11","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/alz.12683","article-title":"The role of mitochondrial dysfunction in Alzheimer's disease pathogenesis","volume":"19","author":"Ashleigh","year":"2023","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.neuint.2024.105761_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2020.111207","article-title":"Mitophagy and DNA damage signaling in human aging","volume":"186","author":"Babbar","year":"2020","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.neuint.2024.105761_bib13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/biof.1597","article-title":"The effects of statins on microglial cells to protect against neurodegenerative disorders: a mechanistic review","volume":"46","author":"Bagheri","year":"2020","journal-title":"Biofactors"},{"key":"10.1016\/j.neuint.2024.105761_bib14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.brainresbull.2021.06.022","article-title":"The role of endocannabinoid pathway in the neuropathology of Alzheimer's disease: can the inhibitors of MAGL and FAAH prove to be potential therapeutic targets against the cognitive impairment associated with Alzheimer's disease?","volume":"174","author":"Bajaj","year":"2021","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuint.2024.105761_bib15","doi-asserted-by":"crossref","DOI":"10.1080\/19336950.2023.2176984","article-title":"L-type calcium channels and neuropsychiatric diseases: insights into genetic risk variant-associated genomic regulation and impact on brain development","volume":"17","author":"Baker","year":"2023","journal-title":"Channels"},{"key":"10.1016\/j.neuint.2024.105761_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126561","article-title":"Insights into role of microRNA in Alzheimer's disease: from contemporary research to bedside perspective","volume":"253","author":"Bandakinda","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.neuint.2024.105761_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121695","article-title":"Memantine, an NMDA receptor antagonist, protected the brain against the long-term consequences of sepsis in mice","volume":"323","author":"Bardaghi","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.neuint.2024.105761_bib18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s40120-020-00218-z","article-title":"CRISPR-Cas9: a promising genome editing therapeutic tool for alzheimer's disease\u2014a narrative review","volume":"9","author":"Barman","year":"2020","journal-title":"Neurol Ther"},{"key":"10.1016\/j.neuint.2024.105761_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.1014659","article-title":"Fluorescence microscopy imaging of a neurotransmitter receptor and its cell membrane lipid milieu","volume":"9","author":"Barrantes","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.neuint.2024.105761_bib20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.exger.2016.12.006","article-title":"A state of delirium: deciphering the effect of inflammation on tau pathology in Alzheimer's disease","volume":"94","author":"Barron","year":"2017","journal-title":"Exp. Gerontol."},{"issue":"2021","key":"10.1016\/j.neuint.2024.105761_bib21","article-title":"Mitochondrial dysfunction in alzheimer's disease: a biomarker of the future?","volume":"9","author":"Bell","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.neuint.2024.105761_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105192","article-title":"New perspectives on the basal forebrain cholinergic system in Alzheimer's disease","volume":"150","author":"Berry","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuint.2024.105761_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2023.105509","article-title":"Oxidative stress: a target to treat Alzheimer's disease and stroke","volume":"165","author":"Briyal","year":"2023","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2024.105761_bib24","first-page":"255","article-title":"Clinical development of aducanumab, an anti-a\u03b2 human monoclonal antibody being investigated for the treatment of early alzheimer's disease","volume":"4","author":"Budd Haeberlein","year":"2017","journal-title":"J Prev Alzheimers Dis"},{"issue":"1 43","key":"10.1016\/j.neuint.2024.105761_bib25","first-page":"4","article-title":"CB1 receptor signaling in the brain: extracting specificity from ubiquity","volume":"43","author":"Busquets-Garcia","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuint.2024.105761_bib26","first-page":"1751","author":"Calcul","year":"2012"},{"key":"10.1016\/j.neuint.2024.105761_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2021.118998","article-title":"In vivo brain imaging of mitochondrial Ca2+ in neurodegenerative diseases with multiphoton microscopy","volume":"1868","author":"Calvo-Rodriguez","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.neuint.2024.105761_bib28","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1006\/bbrc.1998.8866","article-title":"Cyclosporin A increases resting mitochondrial membrane potential in SY5Y cells and reverses the depressed mitochondrial membrane potential of alzheimer's disease cybrids","volume":"248","author":"Cassarino","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuint.2024.105761_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2019.01208","article-title":"miR-212 and miR-132 are downregulated in neurally derived plasma exosomes of alzheimer's patients","volume":"13","author":"Cha","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuint.2024.105761_bib30","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3233\/JAD-170613","article-title":"Mitochondrial translocase of the outer membrane alterations may underlie dysfunctional oxidative phosphorylation in alzheimer's disease","volume":"61","author":"Chai","year":"2018","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuint.2024.105761_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2019.00311","article-title":"Dysfunctional mitochondria and mitophagy as drivers of alzheimer's disease pathogenesis","volume":"11","author":"Chakravorty","year":"2019","journal-title":"Front. Aging Neurosci."},{"issue":"3 41","key":"10.1016\/j.neuint.2024.105761_bib32","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s12640-023-00634-7","article-title":"Challenges and opportunities of metal chelation therapy in trace metals overload-induced alzheimer's disease","volume":"41","author":"Chaudhari","year":"2023","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuint.2024.105761_bib33","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1080\/15548627.2017.1363950","article-title":"Presenilins at the crossroad of a functional interplay between PARK2\/PARKIN and PINK1 to control mitophagy: implication for neurodegenerative diseases","volume":"13","author":"Checler","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.neuint.2024.105761_bib34","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12774","article-title":"Melatonin ameliorates cognitive deficits through improving mitophagy in a mouse model of Alzheimer's disease","volume":"71","author":"Chen","year":"2021","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.neuint.2024.105761_bib35","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S1474-4422(20)30314-8","article-title":"Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias","volume":"19","author":"Ch\u00e9telat","year":"2020","journal-title":"Lancet Neurol."},{"issue":"2021","key":"10.1016\/j.neuint.2024.105761_bib36","article-title":"Natural marine and terrestrial compounds as modulators of matrix metalloproteinases-2 (MMP-2) and MMP-9 in alzheimer's disease","volume":"14","author":"Ciccone","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.neuint.2024.105761_bib37","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s13760-013-0267-6","article-title":"Genome-wide analysis of DNA methylation in an APP\/PS1 mouse model of Alzheimer's disease","volume":"114","author":"Cong","year":"2014","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.neuint.2024.105761_bib38","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4161\/auto.19048","article-title":"Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo","volume":"8","author":"Congdon","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.neuint.2024.105761_bib39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1474-4422(21)00369-0","article-title":"Safety, efficacy, and tolerability of memantine for cognitive and adaptive outcome measures in adolescents and young adults with Down syndrome: a randomised, double-blind, placebo-controlled phase 2 trial","volume":"21","author":"Costa","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuint.2024.105761_bib40","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.neurobiolaging.2013.04.027","article-title":"Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer's disease","volume":"34","author":"Darreh-Shori","year":"2013","journal-title":"Neurobiol. Aging"},{"issue":"7 2","key":"10.1016\/j.neuint.2024.105761_bib41","first-page":"783","article-title":"Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules","volume":"2","author":"Del","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuint.2024.105761_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/alz.061840","article-title":"Using an external control to contextualize efficacy data from patients with prodromal and mild Alzheimer's disease treated with gantenerumab in SCarlet RoAD and Marguerite RoAD open-label extension studies","volume":"18","author":"Delmar","year":"2022","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.neuint.2024.105761_bib43","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1002\/alz.13081","article-title":"Prevalence of Alzheimer's disease dementia in the 50 US states and 3142 counties: a population estimate using the 2020 bridged-race postcensal from the National Center for Health Statistics","volume":"19","author":"Dhana","year":"2023","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.neuint.2024.105761_bib44","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/625659","article-title":"Serum MicroRNA profiles serve as novel biomarkers for the diagnosis of alzheimer's disease","author":"Dong","year":"2015","journal-title":"Dis. Markers"},{"key":"10.1016\/j.neuint.2024.105761_bib45","doi-asserted-by":"crossref","first-page":"S535","DOI":"10.3233\/JAD-2010-100342","article-title":"Mitochondrial amyloid-\u03b2 levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in alzheimer's transgenic mice","volume":"20","author":"Dragicevic","year":"2010","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuint.2024.105761_bib46","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jad.2023.02.129","article-title":"The relationship between depressive symptoms and cognitive function in Alzheimer's disease: the mediating effect of amygdala functional connectivity and radiomic features","volume":"330","author":"Du","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuint.2024.105761_bib47","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1517\/13543784.2012.703178","article-title":"Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis","volume":"21","author":"Dunkel","year":"2012","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.neuint.2024.105761_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-019-1473-9","article-title":"Ultrastructural evidence of microglial heterogeneity in Alzheimer's disease amyloid pathology","volume":"16","author":"El Hajj","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuint.2024.105761_bib49","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1172\/JCI18162","article-title":"NSAIDs and enantiomers of flurbiprofen target \u03b3-secretase and lower A\u03b242 in vivo","volume":"112","author":"Eriksen","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuint.2024.105761_bib50","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.mcn.2019.06.009","article-title":"Mitochondrial dynamics and transport in Alzheimer's disease","volume":"98","author":"Flannery","year":"2019","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuint.2024.105761_bib51","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.nrl.2015.03.012","article-title":"Una revisi\u00f3n de los avances en la terap\u00e9utica de la enfermedad de Alzheimer: estrategia frente a la prote\u00edna \u03b2-amiloide","volume":"33","author":"Folch","year":"2018","journal-title":"Neurologia"},{"key":"10.1016\/j.neuint.2024.105761_bib52","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.expneurol.2009.09.014","article-title":"A\u03b2 exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease","volume":"223","author":"Folwell","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2024.105761_bib53","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.dadm.2019.05.001","article-title":"Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer's disease","volume":"11","author":"Fossati","year":"2019","journal-title":"Alzheimer's Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"10.1016\/j.neuint.2024.105761_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102033","article-title":"The neurobiology and therapeutic potential of multi-targeting \u03b2-secretase, glycogen synthase kinase 3\u03b2 and acetylcholinesterase in Alzheimer's disease","volume":"90","author":"Fronza","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neuint.2024.105761_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23339","article-title":"Ethnobotanical significance of medicinal plants: beta-amyloid and tau aggregation inhibitors against Alzheimer's disease","volume":"37","author":"Ganapathy","year":"2023","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.neuint.2024.105761_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2021.110017","article-title":"Integrated positron emission tomography\/magnetic resonance imaging in clinical diagnosis of alzheimer's disease","volume":"145","author":"Gao","year":"2021","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.neuint.2024.105761_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2023.102757","article-title":"Mitochondrial Ca2+ signaling and Alzheimer's disease: too much or too little?","volume":"113","author":"Garcia-Casas","year":"2023","journal-title":"Cell Calcium"},{"key":"10.1016\/j.neuint.2024.105761_bib58","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/alz.12822","article-title":"Estimating prevalence of early Alzheimer's disease in the United States, accounting for racial and ethnic diversity","volume":"19","author":"Gillis","year":"2023","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.neuint.2024.105761_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.674071","article-title":"Insights into parkin-mediated mitophagy in alzheimer's disease: a systematic review","volume":"13","author":"Goudarzi","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuint.2024.105761_bib60","doi-asserted-by":"crossref","first-page":"17213","DOI":"10.1073\/pnas.0508575102","article-title":"Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer \u03b2-amyloid peptide in rodent","volume":"102","author":"Greig","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuint.2024.105761_bib61","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1185\/03007990152673800","article-title":"A new therapeutic target in alzheimer's disease treatment: attention to butyrylcholinesterase","volume":"17","author":"Greig","year":"2001","journal-title":"Curr. Med. Res. Opin."},{"issue":"3 38","key":"10.1016\/j.neuint.2024.105761_bib62","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s11011-022-01139-6","article-title":"Research progress of PPAR\u03b3 regulation of cholesterol and inflammation in Alzheimer's disease","volume":"38","author":"Gu","year":"2023","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuint.2024.105761_bib63","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.tips.2013.08.008","article-title":"Amygdala FAAH and anandamide: mediating protection and recovery from stress","volume":"34","author":"Gunduz-Cinar","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuint.2024.105761_bib64","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12038-018-9744-7","article-title":"Electromagnetic radiation 2450 MHz exposure causes cognition deficit with mitochondrial dysfunction and activation of intrinsic pathway of apoptosis in rats","volume":"43","author":"Gupta","year":"2018","journal-title":"J. Biosci."},{"key":"10.1016\/j.neuint.2024.105761_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuint.2019.04.001","article-title":"Long-term exposure of 2450 MHz electromagnetic radiation induces stress and anxiety like behavior in rats","volume":"128","author":"Gupta","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2024.105761_bib66","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201949801","article-title":"Mitophagy regulates integrity of mitochondria at synapses and is critical for synaptic maintenance","volume":"21","author":"Han","year":"2020","journal-title":"EMBO Rep."},{"key":"10.1016\/j.neuint.2024.105761_bib67","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.bbalip.2010.01.010","article-title":"Multi-dimensional mass spectrometry-based shotgun lipidomics and the altered lipids at the mild cognitive impairment stage of Alzheimer's disease","volume":"1801","author":"Han","year":"2010","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.neuint.2024.105761_bib68","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neuint.2024.105761_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.702675","article-title":"Pharmacological properties, therapeutic potential and molecular mechanisms of JWH133, a CB2 receptor-selective agonist","volume":"12","author":"Hashiesh","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuint.2024.105761_bib70","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1006\/meth.1996.0116","article-title":"Genetically engineered animal models of alzheimer's disease","volume":"10","author":"Higgins","year":"1996","journal-title":"Methods"},{"issue":"8 29","key":"10.1016\/j.neuint.2024.105761_bib71","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/s41591-023-02443-z","article-title":"CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer's disease","volume":"29","author":"Horie","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuint.2024.105761_bib72","first-page":"353","article-title":"Clinical implementation of Lecanemab: challenges, questions and solutions","volume":"10","author":"Iwatsubo","year":"2023","journal-title":"Journal of Prevention of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.neuint.2024.105761_bib73","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.phytol.2023.01.004","article-title":"Synthesis of piperine analogues as AChE and BChE inhibitors for the treatment of Alzheimer's disease","volume":"53","author":"Jaipea","year":"2023","journal-title":"Phytochem. Lett."},{"key":"10.1016\/j.neuint.2024.105761_bib74","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/acn3.274","article-title":"CSF A\u03b242\/A\u03b240 and A\u03b242\/A\u03b238 ratios: better diagnostic markers of Alzheimer disease","volume":"3","author":"Janelidze","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"issue":"2021","key":"10.1016\/j.neuint.2024.105761_bib75","article-title":"The role of butyrylcholinesterase and iron in the regulation of cholinergic network and cognitive dysfunction in alzheimer's disease pathogenesis","volume":"22","author":"Jasiecki","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2024.105761_bib76","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3390\/biom9100592","article-title":"Butyrylcholinesterase protein ends in the pathogenesis of alzheimer's disease\u2014could BCHE genotyping Be helpful in alzheimer's therapy?","volume":"9","author":"Jasiecki","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.neuint.2024.105761_bib77","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3390\/molecules28031388","article-title":"In silico drug design and analysis of dual amyloid-beta and tau protein-aggregation inhibitors for alzheimer's disease treatment","volume":"28","author":"Job","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.neuint.2024.105761_bib78","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1021\/np100572z","article-title":"The diarylheptanoid (+)-aR,11S-myricanol and two flavones from bayberry (Myrica cerifera) destabilize the microtubule-associated protein tau","volume":"74","author":"Jones","year":"2011","journal-title":"J. Nat. Prod. (Lloydia)"},{"key":"10.1016\/j.neuint.2024.105761_bib79","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.bbalip.2010.04.005","article-title":"Genetic evidence for the involvement of lipid metabolism in Alzheimer's disease","volume":"1801","author":"Jones","year":"2010","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.neuint.2024.105761_bib80","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1111\/jgs.18312","article-title":"Pragmatic evaluation of events and benefits of lipid lowering in older adults (PREVENTABLE): trial design and rationale","volume":"71","author":"Joseph","year":"2023","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.neuint.2024.105761_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1053680","article-title":"Regulatory role of the endocannabinoid system on glial cells toward cognitive function in Alzheimer's disease: a systematic review and meta-analysis of animal studies","volume":"14","author":"Kamaruzzaman","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuint.2024.105761_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007917","article-title":"Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of alzheimer's disease","volume":"4","author":"Ke","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2024.105761_bib83","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jamaneurol.2015.1867","article-title":"Neurogranin as a cerebrospinal fluid biomarker for synaptic loss in symptomatic alzheimer disease","volume":"72","author":"Kester","year":"2015","journal-title":"JAMA Neurol."},{"issue":"2019","key":"10.1016\/j.neuint.2024.105761_bib84","article-title":"MST1 regulates neuronal cell death via JNK\/Casp3 signaling pathway in HFD mouse brain and HT22 cells","volume":"20","author":"Khan","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2024.105761_bib85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195469","article-title":"Memory deficiency, cerebral amyloid angiopathy, and amyloid-\u03b2 plaques in APP+PS1 double transgenic rat model of Alzheimer's disease","volume":"13","author":"Klakotskaia","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2024.105761_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.113409","article-title":"Galantamine-Memantine combination in the treatment of Alzheimer's disease and beyond","volume":"293","author":"Koola","year":"2020","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.neuint.2024.105761_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.00288","article-title":"The regulation of microRNAs in alzheimer's disease","volume":"11","author":"Kou","year":"2020","journal-title":"Front. Neurol."},{"issue":"1 8","key":"10.1016\/j.neuint.2024.105761_bib88","first-page":"1","article-title":"Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer's disease","volume":"8","author":"Kumar","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2024.105761_bib89","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1021\/acschemneuro.8b00220","article-title":"4,6-Diphenylpyrimidine derivatives as dual inhibitors of monoamine oxidase and acetylcholinesterase for the treatment of alzheimer's disease","volume":"10","author":"Kumar","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuint.2024.105761_bib90","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejmech.2018.02.078","article-title":"Development of Piperazinediones as dual inhibitor for treatment of Alzheimer's disease","volume":"150","author":"Kumar","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.neuint.2024.105761_bib91","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pbb.2018.11.009","article-title":"Biological profiling of piperazinediones for the management of anxiety","volume":"176","author":"Kumar","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuint.2024.105761_bib92","article-title":"Benzimidazole-derived carbohydrazones as dual monoamine oxidases and acetylcholinesterase inhibitors: design, synthesis, and evaluation","author":"Kumar","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.neuint.2024.105761_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/alzrt246","article-title":"Perspectives on future Alzheimer therapies: amyloid-\u03b2 protofibrils-A new target for immunotherapy with BAN2401 in Alzheimer's disease","volume":"6","author":"Lannfelt","year":"2014","journal-title":"Alzheimer's Res. Ther."},{"issue":"1 14","key":"10.1016\/j.neuint.2024.105761_bib94","first-page":"1","article-title":"An aging, pathology burden, and glial senescence build-up hypothesis for late onset Alzheimer's disease","volume":"14","author":"Lau","year":"2023","journal-title":"Nat. Commun."},{"issue":"13012 22","key":"10.1016\/j.neuint.2024.105761_bib95","article-title":"miRNAs as therapeutic tools in alzheimer's disease","volume":"22","author":"Lee","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2024.105761_bib96","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.neuint.2010.10.010","article-title":"Intact cannabinoid CB1 receptors in the Alzheimer's disease cortex","volume":"57","author":"Lee","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2024.105761_bib97","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/15548627.2018.1528812","article-title":"Transgenic expression of a ratiometric autophagy probe specifically in neurons enables the interrogation of brain autophagy in vivo","volume":"15","author":"Lee","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.neuint.2024.105761_bib98","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0197-4580(03)00086-1","article-title":"Neurochemical diagnosis of Alzheimer's dementia by CSF A\u03b242, A\u03b242\/A\u03b240 ratio and total tau","volume":"25","author":"Lewczuk","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuint.2024.105761_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116393","article-title":"Yuanzhi Powder inhibits tau pathology in SAMP8 mice: mechanism research of a traditional Chinese formula against Alzheimer's disease","volume":"311","author":"Li","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.neuint.2024.105761_bib100","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ame2.12092","article-title":"Current state of research on non-human primate models of Alzheimer's disease","volume":"2","author":"Li","year":"2019","journal-title":"Animal Model Exp Med"},{"key":"10.1016\/j.neuint.2024.105761_bib102","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.csbj.2014.09.011","article-title":"Cell-based models to investigate tau aggregation","volume":"12","author":"Lim","year":"2014","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.neuint.2024.105761_bib103","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0197-4580(02)00224-5","article-title":"Gene expression analysis in a transgenic Caenorhabditis elegans Alzheimer's disease model","volume":"24","author":"Link","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuint.2024.105761_bib104","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neurobiolaging.2019.02.008","article-title":"Using stem cell\u2013derived neurons in drug screening for neurological diseases","volume":"78","author":"Little","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuint.2024.105761_bib105","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12035-022-03032-w","article-title":"Carnosic acid attenuates A\u03b2Os-induced apoptosis and synaptic impairment via regulating NMDAR2B and its downstream cascades in SH-SY5Y cells","volume":"60","author":"Liu","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuint.2024.105761_bib106","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/00207454.2020.1733564","article-title":"Vascular endothelial growth factor alleviates mitochondrial dysfunction and suppression of mitochondrial biogenesis in models of Alzheimer's disease","volume":"131","author":"Liu","year":"2021","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.neuint.2024.105761_bib107","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.sajb.2023.03.007","article-title":"A triterpenoid saponin bacoside-A3 from the aerial parts of Bacopa monnieri (L.) Wettst. with acetylcholinesterase enzyme combating Alzheimer's disease","volume":"156","author":"Logesh","year":"2023","journal-title":"South Afr. J. Bot."},{"key":"10.1016\/j.neuint.2024.105761_bib108","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1080\/13543784.2022.2095261","article-title":"ALZT-OP1: an experimental combination regimen for the treatment of Alzheimer's disease","volume":"31","author":"Lozupone","year":"2022","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.neuint.2024.105761_bib109","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jpha.2021.06.001","article-title":"Pharmacokinetics, distribution, and excretion of sodium oligomannate, a recently approved anti-Alzheimer\u2019s disease drug in China","volume":"12","author":"Lu","year":"2022","journal-title":"J Pharm Anal"},{"key":"10.1016\/j.neuint.2024.105761_bib110","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/j.1468-1331.2010.03038.x","article-title":"A novel MRI-biomarker candidate for Alzheimer's disease composed of regional brain volume and perfusion variables","volume":"17","author":"Luckhaus","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuint.2024.105761_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110268","article-title":"Clioquinol induces autophagy by down-regulation of calreticulin in human neurotypic SH-SY5Y cells","volume":"369","author":"Lv","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.neuint.2024.105761_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2023.148616","article-title":"Antioxidative and neuroprotective potential of Acorus calamus linn. and Cordia dichotoma G. Forst. In Alzheimer's type dementia in rodent","volume":"1822","author":"Malik","year":"2024","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2024.105761_bib113","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3233\/JAD-210122","article-title":"A high fat\/cholesterol diet recapitulates some alzheimer's disease-like features in mice: focus on hippocampal mitochondrial dysfunction","volume":"82","author":"Mancini","year":"2021","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuint.2024.105761_bib114","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3233\/JAD-190086","article-title":"Mitophagy failure in APP and tau overexpression model of alzheimer's disease","volume":"70","author":"Mart\u00edn-Maestro","year":"2019","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuint.2024.105761_bib115","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2017.00291","article-title":"Mitophagy failure in fibroblasts and iPSC-derived neurons of alzheimer's disease-associated presenilin 1 mutation","volume":"10","author":"Mart\u00edn-Maestro","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuint.2024.105761_bib116","doi-asserted-by":"crossref","first-page":"8220","DOI":"10.1007\/s12035-019-01665-y","article-title":"Autophagy induction by bexarotene promotes mitophagy in presenilin 1 familial alzheimer's disease iPSC-derived neural stem cells","volume":"56","author":"Mart\u00edn-Maestro","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuint.2024.105761_bib117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-022-01124-2","article-title":"Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study","volume":"14","author":"McDade","year":"2022","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.neuint.2024.105761_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2023.102573","article-title":"Structural basis of bioenergetic protein complexes in Alzheimer's disease pathogenesis","volume":"80","author":"McGregor","year":"2023","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.neuint.2024.105761_bib119","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S1474-4422(22)00529-4","article-title":"Lecanemab slows Alzheimer's disease: hope and challenges","volume":"22","author":"Mead","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuint.2024.105761_bib120","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pharmthera.2016.06.011","article-title":"Microglia activation states and cannabinoid system: therapeutic implications","volume":"166","author":"Mecha","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuint.2024.105761_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.vibspec.2023.103510","article-title":"Amyloid \u2013\u03b2 pathology in Alzheimer's disease: a nano delivery approach","volume":"126","author":"Meghana","year":"2023","journal-title":"Vib. Spectrosc."},{"issue":"2023","key":"10.1016\/j.neuint.2024.105761_bib122","article-title":"Molecular multi-target approach for human acetylcholinesterase, butyrylcholinesterase and \u03b2-secretase 1: next generation for alzheimer's disease treatment","volume":"16","author":"Mendes","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.neuint.2024.105761_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103025","article-title":"Design and development of 1,3,4-oxadiazole derivatives as potential inhibitors of acetylcholinesterase to ameliorate scopolamine-induced cognitive dysfunctions","volume":"89","author":"Mishra","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.neuint.2024.105761_bib125","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.semcdb.2022.09.011","article-title":"Retinal organoids from human-induced pluripotent stem cells: from studying retinal dystrophies to early diagnosis of Alzheimer's and Parkinson's disease","volume":"144","author":"M\u00f3vio","year":"2023","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.neuint.2024.105761_bib126","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1586\/14737175.8.11.1703","article-title":"Cholinergic system during the progression of Alzheimer's disease: therapeutic implications","volume":"8","author":"Mufson","year":"2008","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.neuint.2024.105761_bib127","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2014.00189","article-title":"Using the zebrafish model for Alzheimer's disease research","volume":"5","author":"Newman","year":"2014","journal-title":"Front. Genet."},{"key":"10.1016\/j.neuint.2024.105761_bib128","doi-asserted-by":"crossref","DOI":"10.1080\/07391102.2023.2259482","article-title":"In silico identification of novel heterocyclic compounds combats Alzheimer's disease through inhibition of butyrylcholinesterase enzymatic activity","author":"Nguyen","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.neuint.2024.105761_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.127392","article-title":"Phenyl-quinoline derivatives as lead structure of cholinesterase inhibitors with potency to reduce the GSK-3\u03b2 level targeting Alzheimer's disease","volume":"253","author":"Noori","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.neuint.2024.105761_bib130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-020-00614-5","article-title":"Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer's disease spectrum patients: a randomized, double-blind, placebo-controlled study and a two-period extension study","volume":"12","author":"Novak","year":"2020","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.neuint.2024.105761_bib131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-5-45","article-title":"Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden","volume":"5","author":"O'Leary","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuint.2024.105761_bib132","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1037\/0882-7974.8.2.139","article-title":"Behavioral assessment in alzheimer's disease: use of a 24-hr log","volume":"8","author":"O'Leary","year":"1993","journal-title":"Psychol. Aging"},{"key":"10.1016\/j.neuint.2024.105761_bib133","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.2174\/138955707782331678","article-title":"RNA interference as a tool for alzheimers disease therapy","volume":"7","author":"Orlacchio","year":"2007","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.neuint.2024.105761_bib134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-019-0512-1","article-title":"FDG-PET as an independent biomarker for Alzheimer's biological diagnosis: a longitudinal study","volume":"11","author":"Ou","year":"2019","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.neuint.2024.105761_bib135","doi-asserted-by":"crossref","DOI":"10.1002\/9781119711698.ch9","article-title":"Phytosomes-nanoarchitectures\u2019 promising clinical applications and therapeutics","author":"Pal","year":"2021","journal-title":"Nanopharmaceutical Advanced Delivery Systems"},{"key":"10.1016\/j.neuint.2024.105761_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.glohj.2021.11.006","article-title":"A review on emerging smart technological innovations in healthcare sector for increasing patient's medication adherence","volume":"5","author":"Pal","year":"2021","journal-title":"Global Health Journal"},{"key":"10.1016\/j.neuint.2024.105761_bib137","doi-asserted-by":"crossref","DOI":"10.1080\/09205063.2024.2301817","article-title":"Biofabrication paradigms in corneal regeneration: bridging bioprinting techniques, natural bioinks, and stem cell therapeutics","author":"Pal","year":"2024","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.neuint.2024.105761_bib138","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3245935","article-title":"Tau-centric targets and drugs in clinical development for the treatment of alzheimer's disease","volume":"2016","author":"Panza","year":"2016","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.neuint.2024.105761_bib139","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s40268-016-0127-y","article-title":"Safety, tolerability and pharmacokinetics of FAAH inhibitor V158866: a double-blind, randomised, placebo-controlled phase I study in healthy volunteers","volume":"16","author":"Pawsey","year":"2016","journal-title":"Drugs R"},{"key":"10.1016\/j.neuint.2024.105761_bib140","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/978-3-030-57369-0_6","article-title":"Recent advances in the potential of cannabinoids for neuroprotection in alzheimer's, Parkinson's, and huntington's diseases","volume":"1264","author":"P\u00e9rez-Olives","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neuint.2024.105761_bib141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-018-0342-6","article-title":"MH84 improves mitochondrial dysfunction in a mouse model of early Alzheimer's disease","volume":"10","author":"Pohland","year":"2018","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.neuint.2024.105761_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101191","article-title":"Defective mitophagy in Alzheimer's disease","volume":"64","author":"Pradeepkiran","year":"2020","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neuint.2024.105761_bib143","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/alz.12319","article-title":"Whole-genome sequencing reveals new Alzheimer's disease\u2013associated rare variants in loci related to synaptic function and neuronal development","volume":"17","author":"Prokopenko","year":"2021","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.neuint.2024.105761_bib144","first-page":"1","article-title":"Magnetic resonance imaging-negative cerebral amyloid angiopathy: cerebrospinal fluid amyloid-\u03b242 over amyloid positron emission tomography","author":"Pyun","year":"2024","journal-title":"Journal of Prevention of Alzheimer\u2019s Disease"},{"issue":"2021","key":"10.1016\/j.neuint.2024.105761_bib145","article-title":"Exposure to environmental arsenic and emerging risk of alzheimer's disease: perspective mechanisms, management strategy, and future directions","volume":"9","author":"Rahman","year":"2021","journal-title":"Toxics"},{"key":"10.1016\/j.neuint.2024.105761_bib146","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3233\/JAD-2011-101452","article-title":"The effect of metals on spatial memory in a transgenic mouse model of alzheimer's disease","volume":"24","author":"Railey","year":"2011","journal-title":"J. Alzheim. Dis."},{"issue":"10 41","key":"10.1016\/j.neuint.2024.105761_bib147","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/s41401-020-0385-7","article-title":"Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases\u2014focusing on FAAH\/MAGL inhibitors","volume":"41","author":"Ren","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuint.2024.105761_bib148","doi-asserted-by":"crossref","first-page":"17","DOI":"10.12771\/emj.2023.e17","article-title":"Protective effects of statins against alzheimer disease","volume":"46","author":"Rezakhani","year":"2023","journal-title":"The Ewha Medical Journal"},{"key":"10.1016\/j.neuint.2024.105761_bib149","first-page":"142","article-title":"Donanemab in early Alzheimer's Disease. Journal fur Neurologie","volume":"22","author":"Riederer","year":"2021","journal-title":"Neurochirurgie und Psychiatrie"},{"issue":"16 76","key":"10.1016\/j.neuint.2024.105761_bib150","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1007\/s00018-019-03178-2","article-title":"Metalloproteinases and their tissue inhibitors in Alzheimer's disease and other neurodegenerative disorders","volume":"76","author":"Rivera","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuint.2024.105761_bib151","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1039\/C6MB00699J","article-title":"Small RNA sequencing revealed dysregulated piRNAs in Alzheimer's disease and their probable role in pathogenesis","volume":"13","author":"Roy","year":"2017","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.neuint.2024.105761_bib152","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.937056","article-title":"Cholesterol as a key player in amyloid \u03b2-mediated toxicity in Alzheimer's disease","volume":"15","author":"Rudajev","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuint.2024.105761_bib153","doi-asserted-by":"crossref","first-page":"31825","DOI":"10.1074\/jbc.M303588200","article-title":"The non-cyclooxygenase targets of non-steroidal anti-inflammatory drugs, lipoxygenases, peroxisome proliferator-activated receptor, inhibitor of \u03baB kinase, and NF\u03baB, do not reduce amyloid \u03b242 production","volume":"278","author":"Sagi","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"5 17","key":"10.1016\/j.neuint.2024.105761_bib154","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nn.3697","article-title":"Single App knock-in mouse models of Alzheimer's disease","volume":"17","author":"Saito","year":"2014","journal-title":"Nat. Neurosci."},{"issue":"1 120","key":"10.1016\/j.neuint.2024.105761_bib155","first-page":"233","article-title":"What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer's disease, about the therapeutic strategies in Alzheimer's research","volume":"120","author":"Salkovic-Petrisic","year":"2012","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.neuint.2024.105761_bib156","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jad.2020.07.074","article-title":"Regulation of cannabinoid CB1 and CB2 receptors, neuroprotective mTOR and pro-apoptotic JNK1\/2 kinases in postmortem prefrontal cortex of subjects with major depressive disorder","volume":"276","author":"Salort","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuint.2024.105761_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116353","article-title":"Novel 6-alkyl-bridged 4-arylalkylpiperazin-1-yl derivatives of azepino[4,3-b]indol-1(2H)-one as potent BChE-selective inhibitors showing protective effects against neurodegenerative insults","volume":"270","author":"Samarelli","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.neuint.2024.105761_bib158","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/jnc.15116","article-title":"Quantitative proteomic analysis of the frontal cortex in Alzheimer's disease","volume":"156","author":"Sathe","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2024.105761_bib159","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2010.12.012","article-title":"Lest we forget you \u2014 methylene blue","volume":"32","author":"Schirmer","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuint.2024.105761_bib160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011070","article-title":"Neuronal MicroRNA deregulation in response to alzheimer's disease amyloid-\u03b2","volume":"5","author":"Schonrock","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2024.105761_bib161","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11064-022-03734-6","article-title":"Targeting novel microRNAs in developing novel alzheimer's disease treatments","volume":"48","author":"Seyedaghamiri","year":"2023","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuint.2024.105761_bib162","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202203047","article-title":"Synthesis of spiro-oxindole analogs engrafted pyrazole scaffold as potential alzheimer's disease therapeutics: anti-oxidant, enzyme inhibitory and molecular docking approaches","volume":"7","author":"Shahidul Islam","year":"2022","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.neuint.2024.105761_bib163","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2024.148797","article-title":"The neurotransmitter puzzle of Alzheimer's: dissecting mechanisms and exploring therapeutic horizons","volume":"1829","author":"Sharma","year":"2024","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2024.105761_bib164","doi-asserted-by":"crossref","DOI":"10.1007\/s12010-022-04282-z","article-title":"Mechanistic role of methanolic extract of Taraxacum officinale roots as cardioprotective against ischemia\u2013reperfusion injury-induced myocardial infarction in rats","volume":"195","author":"Sharma","year":"2023","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.neuint.2024.105761_bib221","doi-asserted-by":"crossref","first-page":"105685","DOI":"10.1016\/j.neubiorev.2024.105685","article-title":"Regulatory roles of microRNAs in modulating mitochondrial dynamics, amyloid beta fibrillation, microglial activation, and cholinergic signaling: Implications for alzheimer\u2019s disease pathogenesis","volume":"161","author":"Sharma","year":"2024","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.neuint.2024.105761_bib165","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1001\/jamaneurol.2022.2793","article-title":"Association of amyloid reduction after Donanemab treatment with tau pathology and clinical outcomes: the TRAILBLAZER-ALZ randomized clinical trial","volume":"79","author":"Shcherbinin","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuint.2024.105761_bib166","doi-asserted-by":"crossref","first-page":"564","DOI":"10.2174\/156720509790147115","article-title":"Optimized turmeric extracts have potent anti-amyloidogenic effects","volume":"6","author":"Shytle","year":"2009","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neuint.2024.105761_bib167","doi-asserted-by":"crossref","first-page":"708","DOI":"10.4103\/1673-5374.353484","article-title":"Targeting neuroinflammation in Alzheimer's disease: from mechanisms to clinical applications","volume":"18","author":"Si","year":"2023","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.neuint.2024.105761_bib168","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1208968","article-title":"Targeting NMDA receptor in Alzheimer's disease: identifying novel inhibitors using computational approaches","volume":"14","author":"Siddiqui","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuint.2024.105761_bib220","series-title":"Nutrigenomics and Trace Elements: Hopes and Hypes for Parkinson\u2019s Treatment","first-page":"47","author":"Soliman","year":"2023"},{"key":"10.1016\/j.neuint.2024.105761_bib169","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neuroscience.2008.01.044","article-title":"A neuronal model of Alzheimer's disease: an insight into the mechanisms of oxidative stress\u2013mediated mitochondrial injury","volume":"153","author":"Sompol","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2024.105761_bib170","doi-asserted-by":"crossref","first-page":"38118","DOI":"10.1021\/acsomega.3c04261","article-title":"Screening of multitarget-directed natural compounds as drug candidates for alzheimer's disease using in silico techniques: their extraction and in vitro validation","volume":"8","author":"Srivastava","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.neuint.2024.105761_bib171","doi-asserted-by":"crossref","first-page":"898","DOI":"10.4161\/cc.28255","article-title":"Senescence-accelerated OXYS rats: a model of age-related cognitive decline with relevance to abnormalities in Alzheimer disease","volume":"13","author":"Stefanova","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.neuint.2024.105761_bib172","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s00210-017-1417-9","article-title":"Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 ameliorate neuroinflammatory responses in chronic cerebral hypoperfusion model by blocking NF-\u03baB pathways","volume":"390","author":"Su","year":"2017","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"8 12","key":"10.1016\/j.neuint.2024.105761_bib173","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/nprot.2017.060","article-title":"A fluorescence-based imaging method to measure in vitro and in vivo mitophagy using mt-Keima","volume":"12","author":"Sun","year":"2017","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuint.2024.105761_bib174","first-page":"3161","author":"Swetha","year":"2019"},{"key":"10.1016\/j.neuint.2024.105761_bib175","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3233\/JAD-132144","article-title":"Genome-wide serum microRNA expression profiling identifies serum biomarkers for alzheimer's disease","volume":"40","author":"Tan","year":"2014","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuint.2024.105761_bib176","article-title":"Methanolic fraction from Tamala (Diospyros Montana Roxb.) ameliorates anxiety like behaviour via 5-HT2A pathway in rats","volume":"2","author":"Tanwar","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.neuint.2024.105761_bib177","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.drudis.2022.01.016","article-title":"Challenges and hopes for Alzheimer's disease","volume":"27","author":"Tatulian","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.neuint.2024.105761_bib178","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-020-4085-x","article-title":"Use of cannabinoid-based medicine among older residential care recipients diagnosed with dementia: study protocol for a double-blind randomised crossover trial","volume":"21","author":"Timler","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.neuint.2024.105761_bib179","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/mds.25824","article-title":"A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy","volume":"29","author":"Tolosa","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2024.105761_bib180","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/14756366.2017.1389920","article-title":"Design, synthesis, and pharmacological evaluation of 2-amino-5-nitrothiazole derived semicarbazones as dual inhibitors of monoamine oxidase and cholinesterase: effect of the size of aryl binding site","volume":"33","author":"Tripathi","year":"2018","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.neuint.2024.105761_bib181","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2021.102362","article-title":"Mitochondrial dysfunction in neurodegenerative diseases: a focus on iPSC-derived neuronal models","volume":"94","author":"Trombetta-Lima","year":"2021","journal-title":"Cell Calcium"},{"key":"10.1016\/j.neuint.2024.105761_bib182","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.apsb.2021.11.003","article-title":"Mitochondrial complex I as a therapeutic target for Alzheimer's disease","volume":"12","author":"Trushina","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.neuint.2024.105761_bib183","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1189\/jlb.3RU0115-021R","article-title":"Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites","volume":"97","author":"Turcotte","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.neuint.2024.105761_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114354","article-title":"Design, synthesis, and in vitro and in vivo characterization of new memantine analogs for Alzheimer's disease","volume":"236","author":"Turcu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"2021","key":"10.1016\/j.neuint.2024.105761_bib185","article-title":"SSAO\/VAP-1 in cerebrovascular disorders: a potential therapeutic target for stroke and alzheimer's disease","volume":"22","author":"Unzeta","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2024.105761_bib186","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00401-020-02234-7","article-title":"Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer's disease models and human brains","volume":"141","author":"Vaillant-Beuchot","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuint.2024.105761_bib187","article-title":"In vitro and in vivo evaluation of multi-target-directed Rivastigmine\/Memantine\/Gingko biloba-loaded nanofibers against Alzheimer's disease","volume":"86","author":"Veysanoglu","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.neuint.2024.105761_bib188","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2023.340949","article-title":"Cytotoxicity, uptake and accumulation of selenium nanoparticles and other selenium species in neuroblastoma cell lines related to Alzheimer's disease by using cytotoxicity assays, TEM and single cell-ICP-MS","volume":"1249","author":"Vicente-Zurdo","year":"2023","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.neuint.2024.105761_bib189","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/jam.15174","article-title":"Neuroprotective effects of quercetin produced by an endophytic fungus Nigrospora oryzae isolated from Tinospora cordifolia","volume":"132","author":"Vig","year":"2022","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.neuint.2024.105761_bib190","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/13543784.2023.2178414","article-title":"Lecanemab (BAN2401): an anti\u2013beta-amyloid monoclonal antibody for the treatment of Alzheimer disease","volume":"32","author":"Vitek","year":"2023","journal-title":"Expet Opin. Invest. Drugs"},{"issue":"1 16","key":"10.1016\/j.neuint.2024.105761_bib191","first-page":"1","article-title":"The promise of microRNA-based therapies in Alzheimer's disease: challenges and perspectives","volume":"16","author":"Walgrave","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuint.2024.105761_bib192","article-title":"Lecanemab for Alzheimer's disease","volume":"379","author":"Walsh","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.neuint.2024.105761_bib193","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.jinorgbio.2009.07.027","article-title":"APP expression, distribution and accumulation are altered by aluminum in a rodent model for Alzheimer's disease","volume":"103","author":"Walton","year":"2009","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.neuint.2024.105761_bib194","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s11064-014-1343-x","article-title":"Effects of long-term treatment with quercetin on cognition and mitochondrial function in a mouse model of Alzheimer's disease","volume":"39","author":"Wang","year":"2014","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuint.2024.105761_bib195","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.toxlet.2017.10.021","article-title":"Resveratrol attenuates oxidative damage through activating mitophagy in an in vitro model of Alzheimer's disease","volume":"282","author":"Wang","year":"2018","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.neuint.2024.105761_bib196","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3233\/JAD-2010-091207","article-title":"Amyloid-\u03b2 1-42 induces reactive oxygen species-mediated autophagic cell death in U87 and SH-SY5Y cells","volume":"21","author":"Wang","year":"2010","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuint.2024.105761_bib197","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1021\/acschemneuro.8b00391","article-title":"Reconsideration of anticholinesterase therapeutic strategies against alzheimer's disease","volume":"10","author":"Wang","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuint.2024.105761_bib198","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1021\/acschemneuro.3c00358","article-title":"Design, synthesis, and proof of concept of balanced dual inhibitors of butyrylcholinesterase (BChE) and histone deacetylase 6 (HDAC6) for the treatment of alzheimer's disease","volume":"14","author":"Wang","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuint.2024.105761_bib200","first-page":"200","article-title":"Effects of brain cholesterol homeostasis imbalance on Alzheimer's disease and its related molecular mechanisms","volume":"22","author":"Wang","year":"2022","journal-title":"Chinese Journal of Contemporary Neurology and Neurosurgery"},{"key":"10.1016\/j.neuint.2024.105761_bib201","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.febslet.2015.02.001","article-title":"MicroRNA-138 promotes tau phosphorylation by targeting retinoic acid receptor alpha","volume":"589","author":"Wang","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuint.2024.105761_bib205","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2014.00088","article-title":"Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models","volume":"5","author":"Webster","year":"2014","journal-title":"Front. Genet."},{"issue":"6860 414","key":"10.1016\/j.neuint.2024.105761_bib206","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/35102591","article-title":"A subset of NSAIDs lower amyloidogenic A\u03b242 independently of cyclooxygenase activity","volume":"414","author":"Weggen","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2024.105761_bib207","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3233\/JAD-142874","article-title":"Tau aggregation inhibitor therapy: an exploratory phase 2 study in mild or moderate alzheimer's disease","volume":"44","author":"Wischik","year":"2015","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuint.2024.105761_bib208","doi-asserted-by":"crossref","DOI":"10.1002\/alz.066403","article-title":"Normalization methods for RT-qPCR assessment of circulating microRNAs in Alzheimer's and other aging-related diseases","volume":"19","author":"Wojda","year":"2023","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.neuint.2024.105761_bib209","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13371","article-title":"Therapeutic efficacy of novel memantine nitrate MN-08 in animal models of Alzheimer's disease","volume":"20","author":"Wu","year":"2021","journal-title":"Aging Cell"},{"key":"10.1016\/j.neuint.2024.105761_bib210","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.112266","article-title":"Study of mitophagy and ATP-related metabolomics based on \u03b2-amyloid levels in Alzheimer's disease","volume":"396","author":"Xiong","year":"2020","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.neuint.2024.105761_bib211","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3268","article-title":"Long non-coding RNA 00507\/miRNA-181c-5p\/TTBK1\/MAPT axis regulates tau hyperphosphorylation in Alzheimer's disease","volume":"22","author":"Yan","year":"2020","journal-title":"J. Gene Med."},{"key":"10.1016\/j.neuint.2024.105761_bib212","doi-asserted-by":"crossref","DOI":"10.1016\/j.dyepig.2021.109466","article-title":"Research progress of multi-functional fluorescent probes for Alzheimer's disease monitoring","volume":"193","author":"Yang","year":"2021","journal-title":"Dyes Pigments"},{"key":"10.1016\/j.neuint.2024.105761_bib213","doi-asserted-by":"crossref","first-page":"15187","DOI":"10.1021\/acs.jmedchem.0c01192","article-title":"Small molecules selectively targeting sigma-1 receptor for the treatment of neurological diseases","volume":"63","author":"Ye","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuint.2024.105761_bib214","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.912995","article-title":"Mouse models of alzheimer's disease","volume":"15","author":"Yokoyama","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuint.2024.105761_bib215","author":"Yong"},{"key":"10.1016\/j.neuint.2024.105761_bib216","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1002\/hipo.20587","article-title":"Increased hippocampal neurogenesis in the progressive stage of Alzheimer's disease phenotype in an APP\/PS1 double transgenic mouse model","volume":"19","author":"Yu","year":"2009","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuint.2024.105761_bib217","first-page":"313","article-title":"The epidemiology of alzheimer's disease modifiable risk factors and prevention","volume":"8","author":"Zhang","year":"2021","journal-title":"Journal of Prevention of Alzheimer\u2019s Disease"},{"issue":"2019","key":"10.1016\/j.neuint.2024.105761_bib218","article-title":"Discovery of selective butyrylcholinesterase (BChE) inhibitors through a combination of computational studies and biological evaluations","volume":"24","author":"Zhou","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.neuint.2024.105761_bib219","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053117","article-title":"Alzheimer's disease related markers, cellular toxicity and behavioral deficits induced six weeks after oligomeric amyloid-\u03b2 peptide injection in rats","volume":"8","author":"Zussy","year":"2013","journal-title":"PLoS One"}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018624000883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018624000883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T12:30:02Z","timestamp":1717245002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018624000883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":215,"alternative-id":["S0197018624000883"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2024.105761","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in Alzheimer's disease: A multifaceted review of potential therapies and diagnostic techniques for early detection","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2024.105761","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105761"}}